340B Optimization & Compliance

340B is no longer just a pharmacy program. It is a leadership risk area.

For covered entities, 340B can support access, affordability, and financial sustainability. But as scrutiny increases and margins tighten, leadership needs stronger visibility into compliance, performance, and program risk.

Cura helps healthcare organizations evaluate, strengthen, and optimize 340B programs with a focus on governance, documentation, reporting, and long-term sustainability.

The Leadership Challenge

Many 340B programs are operationally complex. Data may be spread across pharmacy systems, split-billing platforms, contract pharmacy arrangements, EHR workflows, finance teams, and compliance processes.

That makes it hard for leaders to clearly see:

Whether program requirements are being followed
Whether savings are being protected
Whether contract pharmacy arrangements are performing
Whether internal controls are strong enough
Whether reporting is reliable
Whether expansion decisions are supported by data

When visibility is weak, 340B risk can build quietly.

What We Help Organizations Address

Cura supports 340B strategy and optimization across:

Program governance review
Internal control assessment
Policy and procedure review
Contract pharmacy strategy
Split-billing workflow review
Compliance readiness

Audit preparation support
Margin and performance visibility
Finance, pharmacy, and leadership alignment
Vendor coordination
Expansion readiness
Reporting and dashboard planning

Why This Matters Now

340B programs are operating in a more complex environment. Covered entities need to protect program integrity while also demonstrating strong oversight and disciplined operations.

Leaders need to know:

Are we prepared for audit scrutiny?
Are our policies current and followed?
Are savings being captured appropriately?
Are vendors performing?
Are program risks visible to leadership?
Are pharmacy, finance, compliance, and operations aligned?
Can we support expansion without creating exposure?

Cura helps organizations move from reactive compliance to proactive program oversight.

How Cura Intervenes

Cura works with leadership and operational teams to assess 340B program structure, visibility, and risk.

We help organizations identify where governance, documentation, data, workflows, or vendor relationships may need attention.

Our approach includes:

What Changes for Leadership

Leaders gain:

Stronger visibility into 340B performance and risk
Better alignment across finance, pharmacy, compliance, and operations
Clearer understanding of margin and sustainability
Improved audit readiness
Stronger governance discipline
Better decision-making around growth and partnerships

Representative Outcomes

Organizations can expect:

Improved program transparency
Reduced compliance exposure
Stronger internal controls
Better vendor oversight
Clearer leadership reporting
More informed expansion decisions
Stronger protection of 340B value

Where Lighthouse Fits

As Lighthouse evolves, 340B-related operational and financial indicators can become part of a broader executive visibility strategy.

The goal is not just to track activity, but to help leadership see where risk, margin, and performance intersect.

Start a Conversation with Cura.

If your 340B program is financially important but difficult to see clearly, Cura can help strengthen visibility, governance, and readiness.